Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
RSS SUMMARY · AGGREGATED FROM CNBC
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Congress moves toward approving $70 billion for ICE and CBP through Trump’s presidency
CNBC·2h ago·3 min read
Business
Food supply ‘not at risk’ after new Texas screwworm cases, USDA secretary says
CNBC·2h ago·3 min read
Business
Household worries over finances hit highest level since July 2022, New York Fed survey shows
CNBC·2h ago·3 min read
Business
United CEO brushes off airline mergers after American rejection: ‘There’s nothing’
CNBC·4h ago·3 min read
Related
On this beat
Business
Talarico lands endorsement from lawyer who defended Paxton in impeachment, securities fraud cases
TT·2h ago·3 min read
Business
Gas prices may surprise you next time you’re at the pump
THE STREET·2h ago·3 min read
Business
Opinion | When ‘60 Minutes’ Is an Hour Too Long
TWSJ·1h ago·3 min read
Business
The 60 Minutes Crisis Reveals the 3 Questions Every Leader Should Be Asking Right Now
INC·1h ago·3 min read